Anthony D'Adamio, SVP & General Counsel at Bioventus Inc. (BVS), sold 5,904 shares at $5.57 ($33K) on 2024-06-21, disclosed to the SEC on 2024-06-25.
Scheduled sale ($33k) by SVP & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BVS | SELL | 2025-02-20 | $45K | — | Filing → |
| BVS | SELL | 2024-12-26 | $123K | — | Filing → |
| BVS | SELL | 2024-06-21 | $132K | — | Filing → |